Novo Nordisk reported DKK14.8B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Bausch Health Companies USD 593M 7M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Novo Nordisk DKK 14.8B 4.96B Mar/2026
Novo Nordisk DKK 4.46B 15.12B Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Sanofi EUR 22.71B 219M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026